Scientific deep-dive

How to Get Ozempic for $25 a Month (Savings Card Guide)

The Ozempic Savings Card can cut your cost to $25/month — but only with commercial insurance for type 2 diabetes. Who qualifies, how to enroll, alternatives.

By Eli Marsden · Founding Editor
Editorially reviewed (not clinically reviewed) · How we verify contentLast reviewed
7 min read·5 citations

The “$25 a month” price for Ozempic comes from one specific source: the Novo Nordisk Ozempic Savings Card, a manufacturer copay card. If you qualify, you can pay as little as $25 for a 1-, 2-, or 3-month supply. But the eligibility rules are strict, and they trip up most people who search for this number. You need commercial (private) insurance that covers Ozempic, and Ozempic is FDA-approved for type 2 diabetes — not weight loss. If you have Medicare, Medicaid, the VA, or TRICARE, you are not eligible. If you are uninsured, you are not eligible. And if you want Ozempic purely for weight loss, the card almost certainly will not apply to you. This guide explains exactly who can get the $25 price, how to enroll, and what to do if you do not qualify.

The eligibility rule that catches most people

The Ozempic Savings Card works only with commercial / private insurance that covers Ozempic for type 2 diabetes. You are NOT eligible if you have any government insurance — Medicare, Medicaid, the VA, TRICARE, or any other federal or state program — or if you are uninsured / paying cash. This is a federal anti-kickback rule, not a Novo Nordisk choice, and there are no exceptions. Verify your current eligibility and the exact terms on the official Novo Nordisk site before you count on the $25 price.

Where the $25 price actually comes from

Ozempic (semaglutide) has a list price of roughly $1,000 per month without insurance. The widely-shared “$25 a month” figure is not a cash price and it is not a discount card like GoodRx. It is the Ozempic Savings Card — a manufacturer copay assistance program run by Novo Nordisk, the company that makes Ozempic. The card sits on top of your existing commercial insurance: your plan pays its negotiated share, and the savings card covers part of what is left, bringing your out-of-pocket cost down to as little as $25 for a 1-, 2-, or 3-month supply of Ozempic. [1]

Two limits define the program, and both matter for whether the $25 holds:

  • A maximum savings per fill. The card pays up to a set dollar amount per prescription fill. If your plan leaves you owing more than the card covers, you pay the difference — so your out-of-pocket cost can be more than $25 on a high-cost plan.
  • An annual maximum savings cap. There is a maximum total amount the card will pay across a calendar year. Once you hit that annual cap, the card stops paying and you revert to your plan’s normal copay or coinsurance for the rest of the year. On a plan with a very high Ozempic price, this can happen before December.

Novo Nordisk sets and changes these dollar amounts periodically, so this guide describes them qualitatively rather than quoting a figure that may already be stale. Always confirm the current per-fill and annual savings maximums on the official Ozempic Savings Card page at NovoCare before you rely on the $25 number. [1] [2]

Who is eligible (and who is not)

You may qualify if you have commercial insurance that covers Ozempic

The savings card is for patients with commercial (private) prescription drug insurance — coverage through an employer, a spouse’s employer, or a plan you bought on the Affordable Care Act marketplace — where that plan covers Ozempic. Because Ozempic is FDA-approved for type 2 diabetes, the on-label prescription your provider writes (and the coverage your plan provides) is for diabetes. [3] If your commercial plan covers Ozempic for type 2 diabetes and you have a valid prescription, you are the patient the savings card is designed for.

You are NOT eligible if any of these apply

  • You have government insurance. Medicare (including Part D and Medicare Advantage), Medicaid, the VA, TRICARE, the Federal Employees Health Benefits Program, or any other state or federal healthcare program — all excluded by federal law. [1]
  • You are uninsured or paying cash. The card reduces a commercial-insurance copay; with no commercial coverage there is no copay for it to reduce.
  • Your commercial plan does not cover Ozempic. If Ozempic is not on your formulary (or is excluded), the savings card has nothing to apply against.

Why government insurance is excluded

Manufacturer copay cards are barred from federal healthcare programs under the federal Anti-Kickback Statute and related rules. This is why every GLP-1 savings card — Ozempic, Wegovy, Mounjaro, Zepbound — carries the same Medicare / Medicaid / VA / TRICARE exclusion. It is not specific to Ozempic and there is no workaround that keeps you on a government plan and still uses the card.

The weight-loss catch: Ozempic vs Wegovy

This is the single most important point for anyone searching for cheap Ozempic to lose weight. Ozempic is FDA-approved for type 2 diabetes, not for weight loss. [3] The Ozempic Savings Card is tied to that on-label diabetes use and to a commercial plan that covers Ozempic for diabetes. People who want Ozempic purely for weight loss commonly run into two walls:

  1. Coverage. Commercial plans cover Ozempic for type 2 diabetes. They generally will not cover — and many providers will not prescribe — Ozempic off-label solely for weight loss, so there is no covered copay for the savings card to reduce.
  2. You may be steered to Wegovy instead. Wegovy is the same molecule (semaglutide) but is the version FDA-approved for chronic weight management. [4] If weight loss is your goal, your provider may prescribe Wegovy rather than Ozempic — and Wegovy has its own separate savings program, not the Ozempic card.

So if your real goal is weight loss, the “$25 Ozempic” path is usually the wrong target. The right targets are the Wegovy savings program (if you have commercial coverage for weight management) or a cash-pay route. The clinical effect is well established — in the STEP-1 trial, semaglutide 2.4 mg produced roughly a 15% mean reduction in body weight over 68 weeks [5] — but that evidence sits behind the Wegovy label, not the Ozempic one.

How to get Ozempic for $25 a month, step by step

  1. Get an Ozempic prescription. See your provider. Ozempic is prescribed on-label for type 2 diabetes; bring your diagnosis and current medications.
  2. Confirm your commercial plan covers Ozempic. Call the member-services number on your insurance card, or check your plan’s formulary, to confirm Ozempic is covered and to learn your copay or coinsurance. Be ready for a possible prior authorization.
  3. Enroll in the Ozempic Savings Card. Sign up at the official Novo Nordisk Ozempic site (NovoCare). Enrollment is free and immediate; you will receive a savings card / offer ID. [1] [2]
  4. Present the card at the pharmacy. Give the pharmacy your insurance and the savings card together. The pharmacy runs your insurance first, then applies the card to reduce what you owe — as little as $25 if your plan’s remaining cost is within the card’s per-fill maximum.
  5. Watch the annual cap. Track how much the card has paid across the year. On a high-cost plan you may hit the annual maximum mid-year, after which you pay your plan’s normal copay until January.

The $25 is not guaranteed all year

Because of the per-fill maximum and the annual savings cap, $25 is a floor for eligible patients, not a promise. On a plan where Ozempic’s remaining cost is very high, your out-of-pocket can exceed $25 per fill, and the annual cap can be exhausted before the calendar year ends. Confirm the current maximums on the official Ozempic Savings Card page.

If you don't qualify: real alternatives

If you have Medicare, Medicaid, the VA, or TRICARE; if you are uninsured; or if you want semaglutide for weight loss rather than diabetes, the Ozempic Savings Card is closed to you. These are the legitimate alternatives:

  • Wegovy savings program (for weight loss). If weight management is the goal and you have commercial coverage for it, Wegovy — the weight-loss semaglutide — has its own copay savings card with the same commercial-only / no-government-insurance rules. [4]
  • Novo Nordisk Patient Assistance Program (PAP). For low-income, uninsured patients, the NovoCare PAP can provide brand-name Novo Nordisk medicines (including Ozempic for diabetes) at no cost to those who meet income and insurance criteria. [2]
  • GoodRx / cash-pay coupons. Discount-card prices are not as low as $25, but they can cut the cash price for those with no usable insurance. See our cash-pay and coupon channel guide for the realistic numbers.
  • Compounded semaglutide. A lower-cost cash option dispensed by licensed pharmacies via telehealth, with important regulatory caveats since the FDA shortage ended. Our buyer guides cover who this fits and the trade-offs.

For the full menu — manufacturer cards, GoodRx, retailer programs, and compounded options side by side — see our GLP-1 cash-pay coupon and channel guide and our cheapest GLP-1 without insurance buyer guide. For how each payer type handles GLP-1s, see our Medicare, Medicaid & commercial coverage breakdown; and if your plan dropped Ozempic, our coverage-appeal playbook walks the appeal. Readers who decide on a cash-pay compounded route can compare vetted telehealth providers on our best semaglutide providers list.

Vetted telehealth providers for cash-pay semaglutide

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

No insurance needed · vetted by our editors

8.6

Enhance MD

Lab-monitored compounded GLP-1 with mandatory video visit

Starting price: $212/mo

Get started →Read review Enhance MD
8.1

Strut Health

Oral-lozenge compounded GLP-1 access

Starting price: $99/mo

Get started →Read review Strut Health
7.9

Live Vital

Shoppers who want low-cost, physician-led compounded GLP-1 with peptide and hormone options

Starting price: $99/mo

Get started →Read review Live Vital
7.9

Get Thin MD

Lowest-priced compounded semaglutide on a 3-month commitment, with brand-name Ozempic/Zepbound also available

Starting price: $199/mo

Get started →Read review Get Thin MD
7.8

Gala

Compounded GLP-1/GIP combo therapy on a yearly subscription with free shipping nationwide

Starting price: $179/mo

Get started →Read review Gala

References

  1. 1.Novo Nordisk Inc. Ozempic (semaglutide) Savings Card — eligibility and copay assistance for commercially insured patients with type 2 diabetes; as little as $25 per 1-, 2-, or 3-month supply, subject to a maximum savings per fill and an annual maximum. Medicare, Medicaid, VA, TRICARE, and uninsured patients are not eligible. Ozempic.com (Novo Nordisk). 2026. https://www.ozempic.com/savings-and-resources/save-on-ozempic.html
  2. 2.Novo Nordisk Inc. NovoCare — patient access, savings offers, and the Novo Nordisk Patient Assistance Program (PAP) for eligible low-income, uninsured patients. novocare.com. 2026. https://www.novocare.com
  3. 3.U.S. Food and Drug Administration. Ozempic (semaglutide) injection — Prescribing Information / FDA label. Indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus (and to reduce cardiovascular risk in certain patients). Not approved for chronic weight management. FDA / DailyMed. 2025. https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/209637s020lbl.pdf
  4. 4.Novo Nordisk Inc. Wegovy (semaglutide) injection — the FDA-approved semaglutide for chronic weight management, with its own separate savings program distinct from the Ozempic Savings Card. Wegovy.com (Novo Nordisk). 2026. https://www.wegovy.com/savings-and-support/save-on-wegovy.html
  5. 5.Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, McGowan BM, Rosenstock J, Tran MTD, Wadden TA, Wharton S, Yokote K, Zeuthen N, Kushner RF; STEP 1 Study Group. Once-Weekly Semaglutide in Adults with Overweight or Obesity. STEP-1. Semaglutide 2.4 mg subcutaneous once-weekly produced approximately a 15% (-14.9%) mean body-weight reduction at week 68. Establishes the weight-management efficacy that sits behind the Wegovy label, not the Ozempic label. N Engl J Med. 2021. PMID: 33567185.

Important disclaimer. This article is educational information only — not medical, legal, or financial advice. GLP-1 cost and eligibility is a YMYL (Your Money or Your Life) topic. Savings-card dollar amounts, the per-fill maximum, the annual savings cap, and eligibility rules are set by Novo Nordisk and change without notice; the figures here are described qualitatively for that reason. Always verify current eligibility and terms on the official Novo Nordisk Ozempic site (NovoCare) before relying on any price. Ozempic is FDA-approved for type 2 diabetes, not weight loss; discuss the right medication and the right savings program for your situation with a licensed prescriber. The clinical claim in this article (STEP-1, PMID 33567185) was verified against the live PubMed E-utilities API on 2026-06-24.

Where to get semaglutide (Ozempic / Wegovy): vetted providers

Vetted telehealth providers that prescribe online, ranked by our editorial score. We compare pricing, form, and states served.

No insurance needed · vetted by our editors

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

7.7

MyStart Health

Fastest compounded GLP-1 onboarding with a price lock

7.6

MEDVi

Patients who want the option to switch between compounded and brand-name GLP-1 through one provider

7.4

RxSpan MD

Shoppers wanting physician-led, pharmacy-transparent compounded GLP-1 with brand-name options